Alveus Therapeutics, Inc., 2026-01-14
An SEC Form D private-offering notice from Philadelphia, PA, a $110,724,980 filer-stated offering target in Biotech. Filed 2026-01-14. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing GLP-1/GIPR fusion protein therapies for obesity and metabolic disease.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SeaLion Energy, Inc., 2026-01-20, $400K, Pittsburgh, PA
- PrognomIQ, Inc., 2026-01-16, $11.9M, San Mateo, CA
- TrueFan Travel, LLC, 2026-01-15, $2.5M, Blue Bell, PA
- Serafin Labs, Inc., 2026-01-14, $1M, San Diego, CA
- NexGelRx, Inc., 2026-01-14, $1.2M, Langhorne, PA
- Rally Tennis Enterprises, Inc, 2026-01-07, $600K, Philadelphia, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.